Marked reduction of the alpha-fetoprotein levels among individuals with chronic hepatitis C, following Peg-interferon and ribavirin treatment

被引：1
|
作者：
Aladag, M [1 ]
Camci, C [1 ]
Huang, Y [1 ]
Wright, H [1 ]
Rizvi, S [1 ]
Gurakar, A [1 ]
Stokes, K [1 ]
Sebastian, A [1 ]
机构：
[1] Integris Baptist Med Ctr, Nazih Zuhdi Transplantat Inst, Div Liver Transplantat Med Hepatol, Oklahoma City, OK 73112 USA
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 2005年 / 39卷 / 10期
关键词：
D O I：
10.1097/01.mcg.0000180801.64575.4f
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：923 / 924
页数：2
相关论文
共 50 条
  • [21] Peg-interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients
    Pawelczyk, T.
    Pawelczyk, A.
    Strzelecki, D.
    Bialkowska, J.
    Jablkowski, M.
    Dworniak, D.
    Rabe-Jablonska, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S526 - S527
  • [22] MULTICENTRE TRIAL OF PEG-INTERFERON α2A & RIBAVIRIN IN PEDIATRIC CHRONIC HEPATITIS C
    Sokal, Etienne M.
    Bourgois, Annick
    Stephenne, Xavier
    Porta, Gilda
    Silveira, Themis R.
    Gordovska, Dace
    Fischler, Bjorn
    Kelly, Deirdre A.
    HEPATOLOGY, 2009, 50 (04) : 418A - 419A
  • [23] Alpha-fetoprotein in chronic hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2011, 110 (11) : 730 - 730
  • [24] Treatment of Recurrent Hepatitis C after Liver Transplantation with PEG-Interferon and Ribavirin.
    Antonino, Anca-Teodora
    Fontana, Massimiliano
    Gioastra, Emiliano
    Moradpour, Darius
    Pascual, Manuel
    LIVER TRANSPLANTATION, 2011, 17 (06) : S149 - S149
  • [25] Peg-interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4
    Shiha, G.
    Abass, B.
    El-Shenawy, H.
    Zalata, K.
    Attia, M.
    Farouk, D.
    LIVER INTERNATIONAL, 2006, 26 : 79 - 79
  • [26] Hepatic steatosis in chronic hepatitis C: impact on response to anti-viral treatment with peg-interferon and ribavirin
    Guidi, M
    Muratori, P
    Granito, A
    Muratori, L
    Pappas, G
    Lenzi, M
    Bianchi, FB
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (10) : 943 - 949
  • [27] Extended Treatment with Peg-Interferon and Ribavirin for Recurrent Hepatitis C after Liver Transplantation
    Tufail, Kashif
    Hashemi, Nikroo
    Azhar, Ashaur
    Feyssa, Eyob
    Niazi, Mumtaz
    Ortiz, Jorge
    Araya, Victor
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S94 - S94
  • [28] The treatment outcome and impact on blood transfusion demand of Peg-interferon/ribavirin in thalassemic patients with chronic hepatitis C
    Liang, Po-Cheng
    Lin, Pei-Chin
    Huang, Ching-I
    Huang, Chung-Feng
    Yeh, Ming-Lun
    Zeng, Yu-Sheng
    Hsu, Wan-Yi
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Huang, Jee-Fu
    Dai, Chia-Yen
    Chuang, Wan-Long
    Chiou, Shyh-Shin
    Yu, Ming-Lung
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2018, 117 (01) : 14 - 23
  • [29] Treatment of chronic hepatitis delta with PEG-interferon alpha-2b.
    Castelnau, C
    Gordien, E
    Boyer, N
    Martinot, M
    Deny, P
    Marcellin, P
    HEPATOLOGY, 2004, 40 (04) : 675A - 675A
  • [30] Improved SVR rates in Southeast Asians with chronic hepatitis C treated with PEG-interferon and ribavirin
    Nguyen, TT
    Rothstein, KD
    Araya, V
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S144 - S144
12345